Inhibitory effects of medicinal plant extracts on interactions between DNA and transcription factors involved in inflammation

Minerva Biotecnologica

Volumn 16, Issue 2, 2004, Pages 93-99

  Lampronti, I ^a   Khan, M T H ^b   Bianchi, N ^a   Borgatti, M ^a   Gambari, R ^a  

^a UNIVERSITY OF FERRARA   (Italy)

^b UNIVERSITY OF SCIENCE AND TECHNOLOGY CHITTAGONG   (Bangladesh)

Author keywords

Anti inflammatory agents; Ethnopharmacology transcription, genetic; Plants, medicinal

Indexed keywords

AEGLE MARMELOS EXTRACT; ANTIINFLAMMATORY AGENT; ARGEMONE OIL; CUSCUTA REFLEXA EXTRACT; CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN; DNA; EMBLICA OFFICINALIS EXTRACT; HERBACEOUS AGENT; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; LAGERSTROEMIA EXTRACT; MORINGA OLEIFERA EXTRACT; NUCLEAR FACTOR; PLANT EXTRACT; RUMEX MARITIMUS EXTRACT; SARACA ASOKA EXTRACT; SMAD PROTEIN; STAT PROTEIN; TERMINALIA ARJUNA EXTRACT; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR AP 1; UNCLASSIFIED DRUG; VERNONIA EXTRACT;

ANALYTIC METHOD; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DNA BINDING; GAS CHROMATOGRAPHY; GEL MOBILITY SHIFT ASSAY; GENE EXPRESSION; GENETIC SCREENING; GENETIC SELECTION; GENETIC TRANSCRIPTION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; INFLAMMATION; LIQUID CHROMATOGRAPHY; MASS SPECTROMETRY; MEDICAL RESEARCH; MEDICINAL PLANT; PROTEIN DNA INTERACTION;

AEGLE MARMELOS; ARGEMONE; ARGEMONE MEXICANA; CUSCUTA; CUSCUTA REFLEXA; LAGERSTROEMIA; MORINGA; MORINGA OLEIFERA; PHYLLANTHUS EMBLICA; RUMEX; RUMEX MARITIMUS; SARACA; TERMINALIA; TERMINALIA ARJUNA; VERNONIA; VERNONIA ANTHELMINTICA;

EID: 4844219781     PISSN: 11204826     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (64)

1. Agarwal N, Gewirtz AM. Oligonucleotide therapeutics for hematologic disorders. Biochim Biophys Acta 1999;1489:85-96.
2. Praseuth D, Guieysse AL, Helene C. Triple helix formation and the antigene strategy for sequence-specific control of gene expression. Biochim Biophys Acta 1999;1489:181-206.
3. Gorman L, Glazer PM. Directed gene modification via triple helix formation. Curr Mol Med 2001;1:391-9.
4. Izumiya Y, Lin SF, Ellison T, Chen LY, Izumiya C, Luciw P et al. Kaposi's sarcoma-associated herpesvirus K-bZIP is a coregulator of K-Rta: physical association and promoter-dependent transcriptional repression. J Virol 2003;77:1441-51.
5. El-Tanani M, Fernig DG, Barraclough R, Green C, Rudland P. Differential modulation of transcriptional activity of estrogen receptors by direct protein-protein interactions with the T cell factor family of transcription factors. J Biol Chem 2001;276:41675-82.
6. Borgatti M, Lampronti I, Romanelli A, Pedone C, Saviano M, Bianchi N et al. Transcription factor decoy molecules based on a peptide nucleic acid (PNA)-DNA chimera mimicking Sp1 binding sites. J Biol Chem 2003;278:7500-9.
7. Yamasaki K, Asai T, Shimizu M, Aoki M, Hashiya N, Sakonjo H et al. Inhibition of NFkappaB activation using cis-element " decoy" of NFkappaB binding site reduces neointimal formation in porcine balloon-injured coronary artery model. Gene Ther 2003;10:356-64.
8. Mann MJ, Dzau VJ. Therapeutic applications of transcription factor decoy oligonucleotides. J Clin Invest 2000;106:1071-5.
9. Cho-Chung YS, Park YG, Lee YN. Oligonucleotides as transcription factor decoys. Curr Opin Mol Ther 1999;1:386-92.
10. Rutigliano C, Bianchi N, Tomassetti M, Pippo L, Mischiati C, Feriotto G et al. Surface plasmon resonance for real-time monitoring of molecular interactions between a triple helix forming oligonucleotide and the Sp1 binding sites of human Ha-ras promoter: effects of the DNA-binding drug chromomycin. Int J Oncol 1998;12:337-43.
11. Aggarwal BB, Schwarz L, Hogan ME, Rando RF. Triple helix-forming oligodeoxyribonucleotides targeted to the human tumor necrosis factor (TNF) gene inhibit TNF production and block the TNF-dependent growth of human glioblastoma tumor cells. Cancer Res 1996;56:5156-64.
12. Mischiati C, Borgatti M, Feriotto G, Rutigliano C, Breda L, Bianchi N et al. Inhibition of HIV-1 LTR-driven in vitro transcription by molecular hybrids based on peptide nucleic acids mimicking the NFkappaB binding site. Int J Mol Med 2002;9:633-9.
13. Gambari R. A guided experimental approach to practical molecular pharmacology teaching: demonstration of sequence selectivity of DNA-binding drugs by arrested polymerase chain reaction. Biochem Educ 2000;28:100-3.
14. Feriotto G, Mischiati C, Gambari R. Sequence-specific recognition of the HIV-1 long terminal repeat by distamycin: a DNase I foot-printing study. Biochem J 1994;299:451-8.
15. Chen F, Demers LM, Shi X. Upstream signal transduction of NFkappaB activation. Curr Drug Targets Inflamm Allergy 2002;1: 137-49.
16. Heasman SJ, Giles KM, Ward C, Rossi AG, Haslett C, Dransfield I. Glucocorticoid-mediated regulation of granulocyte apoptosis and macrophage phagocytosis of apoptotic cells: implications for the resolution of inflammation. J Endocrinol 2003;178:29-36.
17. Hammaker D, Sweeney S, Firestein GS. Signal transduction networks in rheumatoid arthritis. Ann Rheum Dis 2003;62 Suppl 2:ii86-9.
18. Blease K, Lewis A, Raymon HK. Emerging treatments for asthma. Expert Opin Emerg Drug 2003;8:71-81.
19. Loncar MB, Al-azzeh ED, Sommer PS, Marinovic M, Schmehl K, Kruschewski M et al. Tumour necrosis factor alpha and nuclear factor kappaB inhibit transcription of human TFF3 encoding a gastrointestinal healing peptide. Gut 2003;52:1297-303.
20. Wang L, Walia B, Evans J, Gewirtz AT, Merlin D, Sitaraman SV. IL-6 induces NF-kappa B activation in the intestinal epithelia. J Immunol 2003;171:3194-201.
21. Hanada T, Yoshimura A. Regulation of cytokine signaling and inflammation. Cytokine Growth Factor Rev 2002;13:413-21.
22. Yoshimura A, Mori H, Ohishi M, Aki D, Hanada T. Negative regulation of cytokine signaling influences inflammation. Curr Opin Immunol 2003;15:704-8.
23. Olive M, Krylov D, Echlin DR, Gardner K, Taparowsky E, Vinson C. A dominant negative to activation protein-1 (AP1) that abolishes DNA binding and inhibits oncogenesis. J Biol Chem 1997; 272:18586-94.
24. Monteleone G, Mann J, Monteleone I, Vavassori P, Bremner R, Fantini M et al. A failure of TGFbeta 1 negative regulation maintains sustained NF-KB activation in gut inflammation. J Biol Chem 2004;279:3925-32.
25. Kasper LH, Brindle PK, Schnabel CA, Pritchard CE, Cleary ML, van Deursen JM. CREB binding protein interacts with nucleoporin-specific FG repeats that activate transcription and mediate NUP98-HOXA9 oncogenicity. Mol Cell Biol 1999;19:764-76.
26. Hong JH, Hwang ES, Lee CH, Lee YH, Lee SK. dl-propranolol negatively regulates the transcription of proliferating cell nuclear antigen (PCNA)-gene and thereby suppresses DNA synthesis in regenerating rat liver. Biochem Mol Biol Int 1997;42:103-12.
27. Eliopoulos AG, Dumitru CD, Wang CC, Cho J, Tsichlis PN. Induction of COX-2 by LPS in macrophages is regulated by Tpl2-dependent CREB activation signals. EMBO J 2002;21:4831-40.
28. Calo V, Migliavacca M, Bazan V, Macaluso M, Buscemi M, Gebbia N et al. STAT proteins: from normal control of cellular events to tumorigenesis. J Cell Physiol 2003;197:157-68.
29. Gongora C, Mechti N. Interferon signaling pathways. Bull Cancer 1999;86:911-9.
30. Chiao PJ, Hunt KK, Grau AM, Abramian A, Fleming J, Zhang W et al. Tumor suppressor gene Smad4/DPC4, its downstream target genes, and regulation of cell cycle. Ann N Y Acad Sci 1999;880:31-7.
31. Heinrich M, Gibbons S. Ethnopharmacology in drug discovery: an analysis of its role and potential contribution. J Pharm Pharmacol 2001;53:425-32.
32. Borchers AT, Keen CL, Stern JS, Gershwin ME. Inflammation and native american medicine: the role of botanicals. Am J Clin Nutr 2000;72:339-47.
33. Elisabetsky E, Shanley P. Ethnopharmacology in the Brazilian Amazon. Pharmacol Ther 1994;64:201-14.
34. Wickberg B. Chemical methods in ethnopharmacology. J Ethnopharmacol 1993;38:159-65.
35. Hedberg I. Botanical methods in ethnopharmacology and the need for conservation of medicinal plants. J Ethnopharmacol 1993; 38:121-8.
36. Elisabetsky E. Sociopolitical, economical and ethical issues in medicinal plant research. J Ethnopharmacol 1991;32:235-9.
37. Katsube N, Iwashita K, Tsushida T, Yamaki K, Kobori M. Induction of apoptosis in cancer cells by Bilberry (Vaccinium myrtillus) and the anthocyanins. J Agric Food Chem 2003;51:68-75.
38. Khan MT, Lampronti I, Martello D, Bianchi N, Jabbar S, Choudhuri MS et al. Identification of pyrogallol as an antiproliferative compound present in extracts from the medicinal plant Emblica officinalis: effects on in vitro cell growth of human tumor cell lines. Int J Oncol 2002;21:187-92.
39. Couladis M, Badisa RB, Baziou P, Chaudhuri SK, Pilarinou E, Verykokidou E et al. Antioxidant and cytotoxic activities of Hypericum sp. on brine shrimps and human cancer cell lines. Phytother Res 2002;16:719-22.
40. Stevigny C, Block S, De Pauw-Gillet MC, de Hoffmann E, Llabres G, Adjakidje V et al. Cytotoxic aporphine alkaloids from Cassytha filiformis. Planta Med 2002;68:1042-4.
41. Cragg GM, Newman DJ. Discovery and development of antineoplastic agents from natural sources. Cancer Invest 1999;17:153-63.
42. Fotsing MT, Yankep E, Njamen D, Fomum ZT, Nyasse B, Bodo B et al. Identification of an anti-inflammatory principle from the stem bark of Millettia versicolor. Planta Med 2003;69:767-70.
43. Chi YS, Lim H, Park H, Kim HP. Effects of wogonin, a plant flavone from Scutellaria radix, on skin inflammation: in vivo regulation of inflammation-associated gene expression. Biochem Pharmacol 2003;66:1271-8.
44. Jang SI, Kim HJ, Hwang KM, Jekal SJ, Pae HO, Choi BM et al. Hepatoprotective effect of baicalin, a major flavone from Scutellaria radix, on acetaminophen-induced liver injury in mice. Immunopharmacol Immunotoxicol 2003;25:585-94.
45. Blaszczyk T, Krzyzanowska J, Lamer-Zarawska E. Screening for antimycotic properties of 56 traditional Chinese drugs. Phytother Res 2000;14:210-2.
46. Gao Z, Huang K, Yang X, Xu H. Free radical scavenging and antioxidant activities of flavonoids extracted from the radix of Scutellaria baicalensis Georgi. Biochim Biophys Acta 1999;1472: 643-50.
47. Watanabe K, Mimaki Y, Sakagami H, Sashida Y. Bufadienolide and spirostanol glycosides from the rhizomes of helleborusorientalis. J Nat Prod 2003;66:236-41.
48. Zibaeenezhad MJ, Rezaiezadeh M, Mowla A, Ayatollahi SM, Panjehshahin MR. Antihypertriglyceridemic effect of walnut oil. Angiology 2003;54:411-4.
49. Fukuda T, Ito H, Yoshida T. Antioxidative polyphenols from walnuts (Juglans regia L.). Phytochemistry 2003;63:795-801.
50. Kaur K, Michael H, Arora S, Harkonen PL, Kumar S. Studies on correlation of antimutagenic and antiproliferative activities of J uglans regia L. J Environ Pathol Toxicol Oncol 2003;22:59-67.
51. Kolayli S, Kucuk M, Duran C, Candan F, Dincer B. Chemical and antioxidant properties of Laurocerasus officinalis Roem. (cherry laurel) fruit grown in the Black Sea region. J Agric Food Chem 2003; 51:7489-94.
52. Adome RO, Gachihi JW, Onegi B, Tamale J, Apio SO. The cardiotonic effect of the crude ethanolic extract of Nerium oleander in the isolated guinea pig hearts. Afr Health Sci 2003;3:77-86.
53. Choi EM, Hwang JK. Investigations of anti-inflammatory and antinociceptive activities of Piper cubeba, Physalis angulata and Rosa hybrida. J Ethnopharmacol 2003;89:171-5.
54. Pietro RC, Kashima S, Sato DN, Januario AH, Franca SC. In vitro antimycobacterial activities of Physalis angulata L. Phytomedicine 2000;7:335-8.
55. Chiang HC, Jaw SM, Chen CF, Kan WS. Antitumor agent, physalin F from Physalis angulata L. Anticancer Res 1992;12:837-43.
56. Lin YS, Chiang HC, Kan WS, Hone E, Shih SJ, Won MH. Immunomodulatory activity of various fractions derived from Physalis angulata L. extract. Am J Chin Med 1992;20:233-43.
57. Merfort I. Arnica: new insights on the molecular mode of action of a traditional medicinal plant. Forsch Komplementarmed Klass Naturheilkd 2003;10:45-8.
58. Koo H, Gomes BP, Rosalen PL, Ambrosano GM, Park YK, Cury JA. In vitro antimicrobial activity of propolis and Arnica montana against oral pathogens. Arch Oral Biol 2000;45:141-8.
59. Erdemoglu N, Kupeli E, Yesilada E. Anti-inflammatory and antinociceptive activity assessment of plants used as remedy in Turkish folk medicine. J Ethnopharmacol 2003;89:123-9.
60. Kwok BH, Koh B, Ndubuisi MI, Elofsson M, Crews CM. The anti-inflammatory natural product parthenolide from the medicinal herb Feverfew directly binds to and inhibits IkappaB kinase. Chem Biol 2001;8:759-66.
61. Li-Weber M, Giaisi M, Treiber MK, Krammer PH. The anti-inflammatory sesquiterpene lactone parthenolide suppresses IL-4 gene expression in peripheral blood T. Eur J Immunol 2002;32:3587-97.
62. Lee JH, Koo TH, Hwang BY, Lee JJ. Kaurane diterpene, kamebakaurin, inhibits NF-kappa B by directly targeting the DNA-binding activity of p50 and blocks the expression of antiapoptotic NF-kappa B target genes. J Biol Chem 2002;277:18411-20.
63. Surh YJ, Chun KS, Cha HH, Han SS, Keum YS, Park KK et al. Molecular mechanisms underlying chemopreventive activities of anti-inflammatory phytochemicals: down-regulation of COX-2 and iNOS through suppression of NF-kappa B activation. Mutat Res 2001;480-481:243-68.
64. Gerritsen ME, Carley WW, Ranges GE, Shen CP, Phan SA, Ligon GF et al. Flavonoids inhibit cytokine-induced endothelial cell adhesion protein gene expression. Am J Pathol 1995;147:278-92.